Ibrutinib-impurities | Pharmaffiliates

ibrutinib

Ibrutinib is used to treat chronic lymphocytic leukemia Waldenström's macroglobulinemia, and as a second-line treatment for mantle cell lymphoma, marginal zone lymphoma, and chronic graft vs host disease. It is a small molecule drug. Reference standards of Ibrutinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Ibrutinib-d5
    [catalogue_number] => PA STI 052370
    [category_ids] => ,79,80,81,98,
    [chemical_name] => 
    [weight] => 445.53
    [form] => C25H19D5N6O2
    [cas] => 1553977-17-5
    [pslug] => 1553977-17-5-ibrutinib-d5-pasti052370
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 052370

Ibrutinib-d5


  • Catalogue No.:PA STI 052370

  • CAS :

    1553977-17-5

  • Molecular Formula : C25H19D5N6O2

  • Molecular Weight : 445.53

stdClass Object
(
    [pname] => (S)-Ibrutinib-d5
    [catalogue_number] => PA STI 052380
    [category_ids] => ,79,80,81,98,
    [chemical_name] => 
    [weight] => 445.53
    [form] => C25H19D5N6O2
    [cas] => NA
    [pslug] => s-ibrutinib-d5-pasti052380
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 052380

(S)-Ibrutinib-d5


  • Catalogue No.:PA STI 052380

  • CAS :

    NA

  • Molecular Formula : C25H19D5N6O2

  • Molecular Weight : 445.53